Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Status:
Completed
Trial end date:
2005-01-18
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving them in different ways may
kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining topotecan, carboplatin, and
etoposide in treating patients who have extensive-stage small cell lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Wake Forest Baptist Health Wake Forest University Health Sciences